Iterum Therapeutics plc (ITRMF) Notes Payables (2020 - 2023)
Iterum Therapeutics (ITRMF) posted quarterly Notes Payables of $75000.0 for Q3 2023, down 87.7% year-over-year from $610000.0 in Q3 2022, and down 51.3% quarter-over-quarter from $154000.0 in Q2 2023.
Iterum Therapeutics plc (ITRMF) Notes Payables (2020 - 2023) Analysis & Trends
Iterum Therapeutics' Notes Payables history runs 4 years deep, the most recent figure standing at $75000.0 for Q3 2023.
- In Q3 2023, Notes Payables fell 87.7% year-over-year to $75000.0; the TTM figure through Sep 2023 stood at $75000.0 (down 87.7% YoY), while the FY2022 annual figure was $196000.0, down 96.76% from the prior year.
- Notes Payables for Q3 2023 stood at $75000.0, down from $154000.0 in the prior quarter.
- The five-year high for Notes Payables was $28.9 million in Q1 2021, with the low at $75000.0 in Q3 2023.
- The 4-year median for Notes Payables is $6.1 million (2021), against an average of $11.9 million.
- The sharpest annual moves came in 2021 and 2022: Notes Payables advanced 13.84% in 2021, then tumbled 96.76% in 2022.
- Iterum Therapeutics' Notes Payables stood at $28.9 million in 2020, then slumped by 79.01% to $6.1 million in 2021, then sank by 96.76% to $196000.0 in 2022, then tumbled by 61.73% to $75000.0 in 2023.
- Business Quant data shows ITRMF's Notes Payables at $75000.0 in Q3 2023, $154000.0 in Q2 2023, and $187000.0 in Q1 2023.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 75,000.00 |
| Jun 30, 2023 | 154,000.00 |
| Mar 31, 2023 | 187,000.00 |
| Dec 31, 2022 | 196,000.00 |
| Sep 30, 2022 | 610,000.00 |
| Jun 30, 2022 | 1.62 Mn |
| Mar 31, 2022 | 4.45 Mn |
| Dec 31, 2021 | 6.06 Mn |
| Sep 30, 2021 | 9.18 Mn |
| Jun 30, 2021 | 21.86 Mn |
| Mar 31, 2021 | 28.87 Mn |
| Dec 31, 2020 | 28.87 Mn |
| Sep 30, 2020 | 26.10 Mn |
| Jun 30, 2020 | 25.37 Mn |
| Mar 31, 2020 | 25.36 Mn |